NCT01550094

Brief Summary

One technique for the nerve block involves injecting the numbing medicine where the nerve is together (higher up in the back of the thigh). The other technique involves injecting the numbing medicine where the nerve splits into two parts. By injecting numbing medication around the nerve(s), there will be less pain after the procedure. It is thought that the numbing medicine will be easier to inject in the group that the nerves are split. It is expected that subjects may need less pain medication and have lower pain ratings in this group too.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2012

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 9, 2012

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

October 14, 2015

Status Verified

October 1, 2015

Enrollment Period

3.6 years

First QC Date

March 7, 2012

Last Update Submit

October 13, 2015

Conditions

Keywords

obeseregional anesthesiaanesthesiaanesthesiologysurgeryfootfoot surgeryankleankle surgeryorthopedicsorthopedic surgerysports medicinesports medicine surgeryOchsner HospitalOchsner ClinicNew OrleansLouisianaJeffersonSoberon

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Severely and morbidly obese patients scheduled for foot or ankle surgery.

You may qualify if:

  • Patients ≥ 18 years of age undergoing unilateral foot and/or ankle surgery
  • Severe or morbid obesity, defined as a BMI of 35-39 or ≥ 40, respectively
  • ASA status I-IV
  • Ability to understand and provide informed consent

You may not qualify if:

  • True allergy, not sensitivity, to any of the following substances:
  • Local Anesthetics Midazolam Fentanyl Hydromorphone Propofol
  • Pregnancy
  • Evidence of infection at or near the proposed needle insertion site
  • Unstable or undetermined neurologic disease of the lower extremity
  • Chronic pain patients
  • Patient refusal or inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ochsner Clinic Foundation

New Orleans, Louisiana, 70121, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jose Soberon, MD

    Ochsner Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

March 7, 2012

First Posted

March 9, 2012

Study Start

March 1, 2012

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

October 14, 2015

Record last verified: 2015-10

Locations